{"id":82658,"date":"2025-11-18T13:53:00","date_gmt":"2025-11-18T13:53:00","guid":{"rendered":"https:\/\/www.cofb.org\/?p=82658"},"modified":"2025-11-20T13:03:28","modified_gmt":"2025-11-20T13:03:28","slug":"rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/","title":{"rendered":"Rinosinusitis y congesti\u00f3n nasal: novedades en su tratamiento"},"content":{"rendered":"<p>El pasado 28 de octubre, el<strong> Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/strong> (COFB) organiz\u00f3 la formaci\u00f3n \u201c<strong>Rinosinusitis y congesti\u00f3n nasal: novedades basadas en la evidencia y reducci\u00f3n del uso de antibi\u00f3ticos<\/strong>\u201d, con el patrocinio de <a href=\"https:\/\/www.bionorica.es\/\" target=\"_blank\" rel=\"noreferrer noopener\">Bionorica<\/a>. La conferencia corri\u00f3 a cargo de <strong>Manuel Bernal<\/strong>, jefe del Servicio de Otorrinoralingolog\u00eda (ORL) del Hospital Cl\u00ednic de Barcelona; y de<strong>Elena P\u00e9rez<\/strong>, farmac\u00e9utica titular de la farmacia Garc\u00eda P\u00e9rez en L&#039;Hospitalet de Llobregat. La formaci\u00f3n fue coordinada por el vocal de Plantas Medicinales y Homeopat\u00eda del COFB,<strong> Josep Allu\u00e9<\/strong>.<\/p>\n\n\n\n<p>Los <strong>objetivos <\/strong>de la sesi\u00f3n fueron <strong>revisar las situaciones m\u00e1s frecuentes<\/strong> que cursan con<strong> congesti\u00f3n nasal<\/strong>, conocer las <strong>opciones terap\u00e9uticas disponibles <\/strong>y presentar<strong> la evidencia cient\u00edfica m\u00e1s reciente <\/strong>sobre<strong> el uso de medicamentos a base de plantas<\/strong>.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_00-scaled.jpg\" target=\"_blank\" rel=\" noreferrer noopener\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_00-1024x576.jpg\" alt=\"El vocal de Plantes Medicinals del COFB, Josep Allu\u00e9, va destacar que els medicaments amb bases de plantes s\u00f3n una refer\u00e8ncia contra les congestions nasals.\" class=\"wp-image-82663\" srcset=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_00-1024x576.jpg 1024w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_00-300x169.jpg 300w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_00-768x432.jpg 768w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_00-1536x864.jpg 1536w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_00-2048x1152.jpg 2048w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_00-18x10.jpg 18w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><figcaption class=\"wp-element-caption\">El vocal de Plantas Medicinales del COFB, Josep Allu\u00e9, en su presentaci\u00f3n.<\/figcaption><\/figure>\n\n\n\n<p><strong>Josep Allu\u00e9<\/strong>, vocal de Plantas Medicinales del COFB, inaugur\u00f3 la formaci\u00f3n afirmando que \u201c<strong>medicamentos con bases de plantas<\/strong> en distintos pa\u00edses europeos son una referencia. La presencia de estos medicamentos solucionar\u00e1 muchos problemas en la<strong> pr\u00e1ctica diaria de la oficina de farmacia<\/strong> en cuanto a las <strong>congestiones nasales<\/strong>. Todos conocemos las limitaciones existentes en ese aspecto\u201d.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Rinosinusitis y la integraci\u00f3n de la fitoterapia en las gu\u00edas cl\u00ednicas<\/h2>\n\n\n\n<p><strong>Manuel Bernal<\/strong>, jefe de Servicio de ORL del Hospital Cl\u00ednic de Barcelona, inici\u00f3 su sesi\u00f3n explicando que \u201cla <strong>congesti\u00f3n nasal <\/strong>siempre est\u00e1 en el marco de alguna <strong>afectaci\u00f3n rinosinusal<\/strong>. Con el paso de los a\u00f1os, han aparecido tratamientos innovadores a base de <strong>fitof\u00e1rmacos <\/strong>contra la congesti\u00f3n nasal, llegando incluso a usarlos en <strong>detrimento de los antibi\u00f3ticos<\/strong> debido a su eficiencia\u201d.<\/p>\n\n\n\n<p>La<strong> definici\u00f3n cl\u00ednica de la rinosinusitis<\/strong> &quot;ha ido modific\u00e1ndose a trav\u00e9s del paso del tiempo. Cuando un paciente la sufre durante m\u00e1s de diez d\u00edas, se trata de una <strong>rinosinusitis aguda<\/strong>. A partir de las<strong> dos semanas<\/strong>, deber\u00eda hablarse de <strong>rinosinsutis cr\u00f3nica<\/strong>, que genera una obstrucci\u00f3n nasal que no puede eliminarse con antibi\u00f3tico, se necesita otro tipo de abordaje terap\u00e9utico\u201d, explic\u00f3 Bernal.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_01-scaled.jpg\" target=\"_blank\" rel=\" noreferrer noopener\"><img decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_01-1024x576.jpg\" alt=\"Manuel Bernal, en un moment de la seva presentaci\u00f3.\" class=\"wp-image-82664\" srcset=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_01-1024x576.jpg 1024w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_01-300x169.jpg 300w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_01-768x432.jpg 768w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_01-1536x864.jpg 1536w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_01-2048x1152.jpg 2048w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_01-18x10.jpg 18w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><figcaption class=\"wp-element-caption\">Manuel Bernal, en un momento de su presentaci\u00f3n.<\/figcaption><\/figure>\n\n\n\n<p>Para finalizar su ponencia ligada a rinosinusitis y congesti\u00f3n nasal, Bernal mencion\u00f3 la<strong> integraci\u00f3n de la fitoterapia<\/strong> en las gu\u00edas cl\u00ednicas ligadas a la <strong>rinosinusitis<\/strong>: \u201cLos \u00faltimos descubrimientos han respondido a las expectativas de los pacientes de recibir un <strong>tratamiento activo<\/strong>, convirtiendo a esta terapia en una soluci\u00f3n eficaz, segura y avalada por los investigadores\u201d.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Plantas medicinales y el papel del farmac\u00e9utico<\/h2>\n\n\n\n<p>A continuaci\u00f3n,<strong> Elena P\u00e9rez<\/strong>, farmac\u00e9utica titular de la farmacia Garc\u00eda P\u00e9rez en L&#039;Hospitalet de Llobregat, explic\u00f3 su experiencia en la farmacia ligada al <strong>consumo de plantas medicinales<\/strong>: \u201cCada vez hay m\u00e1s demanda de estos productos, y por eso se trata <strong>de una oportunidad<\/strong>. Por tanto, es necesario formarse para poder <strong>dar respuesta a todos los pacientes <\/strong>que piden por este grupo de f\u00e1rmacos\u201d.<\/p>\n\n\n\n<p>La farmac\u00e9utica especific\u00f3 que, cada vez, \u201chay m\u00e1s gente que<strong> se informa de las plantas medicinales<\/strong> \u00fanicamente por <strong>redes sociales<\/strong> y cuando llegan a la farmacia tienen muchas dudas. Es aqu\u00ed donde el profesional debe ordenar y <strong>aclarar toda la informaci\u00f3n <\/strong>respecto a este campo\u201d.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg\" target=\"_blank\" rel=\" noreferrer noopener\"><img decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-1024x576.jpg\" alt=\"La necessitat que el farmac\u00e8utic aclareixi els dubtes dels ciutadans lligats a les plantes medicinals va ser explicada per Elena P\u00e9rez.\" class=\"wp-image-82665\" srcset=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-1024x576.jpg 1024w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-300x169.jpg 300w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-768x432.jpg 768w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-1536x864.jpg 1536w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-2048x1152.jpg 2048w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-18x10.jpg 18w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><figcaption class=\"wp-element-caption\">La farmac\u00e9utica Elena P\u00e9rez, en un momento de su exposici\u00f3n.<\/figcaption><\/figure>\n\n\n\n<p>Para concluir su ponencia, P\u00e9rez destac\u00f3 que \u201cel <strong>70% de espa\u00f1oles consume plantas medicinales<\/strong>, ya que se prefiere una soluci\u00f3n natural que medicaci\u00f3n sint\u00e9tica. La sociedad percibe que es m\u00e1s natural y tiene menos efectos secundarios. Todo esto ayuda a que los farmac\u00e9uticos tengan que formar a sus equipos de los productos naturales que se venden en las farmacias&quot;. Por \u00faltimo, comparti\u00f3 que el farmac\u00e9utico &quot;debe dar un <strong>buen consejo en el \u00e1mbito de medicamentos naturales o sint\u00e9ticos<\/strong>. Hay una gran evidencia cient\u00edfica detr\u00e1s, lo que debe generar tranquilidad a la hora de poder aconsejarle al paciente\u201d.<\/p>\n\n\n\n<p class=\"has-text-align-right\"><strong>Con el patrocinio de:<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image alignright size-full is-resized\"><a href=\"https:\/\/www.bionorica.es\/\" target=\"_blank\" rel=\" noreferrer noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"2536\" height=\"672\" src=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/BIONORICA_2025_transparent.png\" alt=\"\" class=\"wp-image-81874\" style=\"width:268px;height:auto\" srcset=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/BIONORICA_2025_transparent.png 2536w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/BIONORICA_2025_transparent-300x79.png 300w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/BIONORICA_2025_transparent-1024x271.png 1024w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/BIONORICA_2025_transparent-768x204.png 768w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/BIONORICA_2025_transparent-1536x407.png 1536w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/BIONORICA_2025_transparent-2048x543.png 2048w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/07\/BIONORICA_2025_transparent-18x5.png 18w\" sizes=\"(max-width: 2536px) 100vw, 2536px\" \/><\/a><\/figure>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>El pasado 28 de octubre, el Colegio de Farmac\u00e9uticos de Barcelona (COFB) organiz\u00f3 la formaci\u00f3n &quot;Rinosinusitis y congesti\u00f3n nasal: novedades basadas en la evidencia y reducci\u00f3n del uso de antibi\u00f3ticos&quot;, con el patrocinio de Bionorica. La conferencia corri\u00f3 a cargo de Manuel Bernal, jefe del Servicio de Otorrinoralingolog\u00eda (ORL) del Hospital Cl\u00ednic [\u2026]<\/p>","protected":false},"author":10,"featured_media":82665,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[269,18,19,69,70,431,2976],"class_list":["post-82658","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-antibiotics","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-farmacia-comunitaria","tag-formacio","tag-planta-medicinal","tag-vocalia-de-plantes-medicinals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El COFB celebra a la seva seu una nova formaci\u00f3 lligada a rinosinusitis i congesti\u00f3 nasal, amb el patrocini de Bionorica\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/es\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El COFB celebra a la seva seu una nova formaci\u00f3 lligada a rinosinusitis i congesti\u00f3 nasal, amb el patrocini de Bionorica\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/es\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-18T13:53:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-20T13:03:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Xavier Magraner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Xavier Magraner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/\"},\"author\":{\"name\":\"Xavier Magraner\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4\"},\"headline\":\"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament\",\"datePublished\":\"2025-11-18T13:53:00+00:00\",\"dateModified\":\"2025-11-20T13:03:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/\"},\"wordCount\":719,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg\",\"keywords\":[\"antibi\u00f2tics\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"farm\u00e0cia comunit\u00e0ria\",\"Formaci\u00f3\",\"planta medicinal\",\"Vocalia de Plantes Medicinals\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/\",\"url\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/\",\"name\":\"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg\",\"datePublished\":\"2025-11-18T13:53:00+00:00\",\"dateModified\":\"2025-11-20T13:03:28+00:00\",\"description\":\"El COFB celebra a la seva seu una nova formaci\u00f3 lligada a rinosinusitis i congesti\u00f3 nasal, amb el patrocini de Bionorica\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg\",\"width\":2560,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4\",\"name\":\"Xavier Magraner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g\",\"caption\":\"Xavier Magraner\"},\"url\":\"https:\/\/www.cofb.org\/es\/author\/xmagraner\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El COFB celebra a la seva seu una nova formaci\u00f3 lligada a rinosinusitis i congesti\u00f3 nasal, amb el patrocini de Bionorica","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/es\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/","og_locale":"es_ES","og_type":"article","og_title":"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El COFB celebra a la seva seu una nova formaci\u00f3 lligada a rinosinusitis i congesti\u00f3 nasal, amb el patrocini de Bionorica","og_url":"https:\/\/www.cofb.org\/es\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2025-11-18T13:53:00+00:00","article_modified_time":"2025-11-20T13:03:28+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg","type":"image\/jpeg"}],"author":"Xavier Magraner","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"Xavier Magraner","Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/"},"author":{"name":"Xavier Magraner","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4"},"headline":"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament","datePublished":"2025-11-18T13:53:00+00:00","dateModified":"2025-11-20T13:03:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/"},"wordCount":719,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg","keywords":["antibi\u00f2tics","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","farm\u00e0cia comunit\u00e0ria","Formaci\u00f3","planta medicinal","Vocalia de Plantes Medicinals"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/","url":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/","name":"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg","datePublished":"2025-11-18T13:53:00+00:00","dateModified":"2025-11-20T13:03:28+00:00","description":"El COFB celebra a la seva seu una nova formaci\u00f3 lligada a rinosinusitis i congesti\u00f3 nasal, amb el patrocini de Bionorica","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg","width":2560,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4","name":"Xavier Magraner","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g","caption":"Xavier Magraner"},"url":"https:\/\/www.cofb.org\/es\/author\/xmagraner\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg",2560,1440,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-768x432.jpg",768,432,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-1024x576.jpg",1024,576,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-2048x1152.jpg",2048,1152,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-18x10.jpg",18,10,true]},"uagb_author_info":{"display_name":"Xavier Magraner","author_link":"https:\/\/www.cofb.org\/es\/author\/xmagraner\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 28 d\u2019octubre, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar la formaci\u00f3 \u201cRinosinusitis i congesti\u00f3 nasal: novetats basades en l&#8217;evid\u00e8ncia i reducci\u00f3 de l&#8217;\u00fas d&#8217;antibi\u00f2tics\u201d, amb el patrocini de Bionorica. La confer\u00e8ncia va anar a c\u00e0rrec de Manuel Bernal, cap del Servei d&#8217;Otorrinoralingologia (ORL) de l&#8217;Hospital Cl\u00ednic [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/82658","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=82658"}],"version-history":[{"count":12,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/82658\/revisions"}],"predecessor-version":[{"id":82901,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/82658\/revisions\/82901"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media\/82665"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=82658"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=82658"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=82658"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}